- Home
- ITT vs RVMD Comparison
ITT vs RVMD Comparison
Compare ITT & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITT | RVMD |
|---|---|---|
| Founded | 1920 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 15.2B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | ITT | RVMD |
|---|---|---|
| Price | $203.13 | $100.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 16 |
| Target Price | ★ $215.33 | $114.63 |
| AVG Volume (30 Days) | 944.8K | ★ 1.7M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.11 | N/A |
| Revenue | ★ $3,938,500,000.00 | N/A |
| Revenue This Year | $7.48 | N/A |
| Revenue Next Year | $5.50 | $552.08 |
| P/E Ratio | $33.47 | ★ N/A |
| Revenue Growth | ★ 8.48 | N/A |
| 52 Week Low | $105.64 | $29.17 |
| 52 Week High | $209.70 | $124.49 |
Technical Indicators
Market Signals| Indicator | ITT | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.32 | 51.30 |
| Support Level | $175.80 | $92.76 |
| Resistance Level | $207.98 | $124.49 |
| Average True Range (ATR) | 5.72 | 3.64 |
| MACD | -0.42 | 0.09 |
| Stochastic Oscillator | 41.15 | 51.54 |
Price Performance
Historical ComparisonAbout ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.